References
- 1. Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences. 2020;16(10): 1753–1766. Available from: http://www.ijbs.com/v16p1753.htm.10.7150/ijbs.45134
- 2. Park WB, Jun KI, Kim G, Choi JP, Rhee JY, Cheon S, et al. Correlation between pneumonia severity and pulmonary complications in middle east respiratory syndrome. Journal of Korean Medical Science. 2018;33(24): e169. Available from: doi:10.3346/jkms.2018.33.e169.10.3346/jkms.2018.33.e169
- 3. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4): 2247–2261.10.1378/chest.128.4.2247
- 4. Orme J Jr, Romney JS, Hopkins RO, Pope D, Chan KJ, Thomsen G, et al. Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine. 2003;167(5): 690–694.10.1164/rccm.200206-542OC
- 5. Peters JI, Bell RC, Prihoda TJ, Harris G, Andrews C, Johanson WG. Clinical determinants of abnormalities in pulmonary functions in survivors of the adult respiratory distress syndrome. The American Review of Respiratory Disease. 1989;139(5): 1163–1168.10.1164/ajrccm/139.5.1163
- 6. Cheung E. Coronavirus: some recovered patients may have reduced lung function and are left gasping for air while walking briskly, Hong Kong doctors find. South China Morning Post Published: 12:04 am, 13 Mar, 2020.
- 7. Wang JT, Sheng WH, Fang CT, Chen YC, Wang JL, Yu CJ, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerging Infectious Diseases. 2004;10: 818–824.10.3201/eid1005.030640
- 8. Kanne JP. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. 2020;295: 16–17.10.1148/radiol.2020200241
- 9. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-CoV lung injury. Lancet. 2020;395: 473–475.10.1016/S0140-6736(20)30317-2
- 10. Lamontagne F, Rochwerg B, Lytvyn L. Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ. 2018;362: 1–8.10.1136/bmj.k3284608343930097460
- 11. Chen C, Qi F, Shi K, Li Y, Li J, Chen Y, et al. Thalidomide combined with low-dose glucocorticoid in the treatment of COVID-19 pneumonia. Preprints. 2020:2020020395. Available from: https://www.preprints.org/manuscript/202002.0395/v1.
- 12. Tobaiqy M, Qashqary M, Al-Dahery S, et al. Therapeutic management of COVID-19 patients: a systematic review [published online ahead of print, 2020 Apr 17]. 2020;2(3): 100061. doi:10.1016/j.infpip.2020.100061.10.1016/j.infpip.2020.100061716276834316558
- 13. Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, et al. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. American Journal of Respiratory and Critical Care Medicine. 2018;197: 757–767.10.1164/rccm.201706-1172OC29161116
- 14. Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 2020;12(4): e7560. doi:10.7759/cureus.7560.10.7759/cureus.7560713842332269893
- 15. Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research. 2017;143: 142–150.10.1016/j.antiviral.2017.03.022550776928390872
- 16. Zhang W. Imaging changes of severe COVID-19 pneumonia in advanced stage. Intensive Care Medicine. 2020;46: 841–843. [Google Scholar].10.1007/s00134-020-05990-y708001832123986